Should chemoprophylaxis be a main strategy for preventing re-introduction of malaria in highly receptive areas? Sri Lanka a case in point

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Wickremasinghe, A Rajitha ^a   Wickremasinghe, Renu ^b   Herath, Hemantha D B ^c   Fernando, S Deepika ^d  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

^c Sri Lanka Ministry of Health and Nutrition   (Sri Lanka)

^d UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Chemoprophylaxis; Cost; Malaria; Prevention of re introduction; Sri Lanka

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA; MALE; SRI LANKAN; PREVENTION AND CONTROL; PROCEDURES; SRI LANKA; TRAVEL; UTILIZATION;

ANTIMALARIALS; CHEMOPREVENTION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; INDIA; MALARIA; MALE; SRI LANKA; TRAVEL;

EID: 85014484885     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-1763-6     Document Type: Article

References (23)

1. WHO. World Malaria Report 2009. Geneva: World Health Organization; 2009. http://www.who.int/malaria/world-malaria-report-2009/mal2009-rep-chap5-0040.pdf?ua=1. Accessed 30 Dec 2016.
2. Webster-Kerr K, Figueroa JP, Weir PL, Lewis-Bell K, Baker E, Horner Bryce J, et al. Success in controlling a major outbreak of malaria because of Plasmodium falciparum in Jamaica. Trop Med Int Health. 2011;16:298-306.
3. Kho WG, Jang JY, Hong ST, Lee HW, Lee WJ, Lee JS. Border malaria characters of re-emerging vivax malaria in the Republic of Korea. Korean J Parasitol. 1999;37:71-6.
4. Global Health Science Group. Eliminating malaria in the Republic of Korea, Country briefing; 2015. https://globalhealthsciences.ucsf.edu/sites/globalhealthsciences.ucsf.edu/files/pub/rokorea-2015-final.pdf. Accessed 30 Dec 2016.
5. WHO. Regional framework for prevention of malaria re-introduction and certification of malaria elimination 2014-2020. Geneva: World Health Organization; 2014. http://www.euro.who.int/--data/assets/pdf-file/0008/254978/Regional-framework-for-prevention-of-malaria-reintroduction-and-certification-of-malaria-elimination-20142020.pdf. Accessed 30 Dec 2016.
6. Premaratne R, Ortega L, Janakan N, Mendis KN. Malaria elimination in Sri Lanka: what it would take to reach the goal ? WHO South East Asia J Public Health. 2014;3:85-9.
7. Galappaththy G, Fernando SD, Abeyasinghe R. Imported malaria: a possible threat to the elimination of malaria from Sri Lanka? Trop Med Int Health. 2013;18:761-8.
8. WHO. Global Technical Strategy for Malaria 2016-2030. Geneva: World Health Organization; 2015. http://apps.who.int/iris/bitstream/10665/176712/1/9789241564991-eng.pdf?ua=1&ua=1. Accessed 30 Dec 2016.
9. Fernando SD, Dharmawardana P, Semege S, Epasighe G, Senanayake N, Rodrigo C, et al. The risk of imported malaria in security forces personnel returning from overseas missions in the context of prevention of re-introduction of malaria to Sri Lanka. Malar J. 2016;15:144.
10. Global Health Science Group. Investing in prevention of reintroduction of malaria in Sri Lanka; 2016. http://www.shrinkingthemalariamap.org/sites/www.shrinkingthemalariamap.org/files/content/resource/attachment/Sri%20Lanka%20Investment%20Case-Policy%20Brief.pdf. Accessed 30 Dec 2016.
11. WHO. International Travel and Health. Geneva: World Health Organization; 2012. http://who.int/ith/ITH-EN-2012-WEB-1.2.pdf?ua=1. Accessed 30 Dec 2016.
12. Anvikar AR, Shah N, Dhariwal AC, Sonal GS, Pradhan MM, Ghosh SK, et al. Epidemiology of Plasmodium vivax malaria in India. Am J Trop Med Hyg. 2016;95(Suppl 6):108-20.
13. Krishna S, Bharti PK, Chandel HS, Ahmad A, Kumar R, Singh PP, et al. Detection of mixed infections with Plasmodium spp. by PCR, India, 2014. Emerg Infect Dis. 2015;21:1853-7.
14. Shah NK, Dhillon GPS, Dash AP, Arora U, Meshnick SR, Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis. 2011;11:57-64.
15. Anti Malaria Campaign, Sri Lanka. 2014. Treatment guidelines. http://www.malariacampaign.gov.lk.
16. Ritchie EC, Block J, Nevin RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law. 2013;41:224-35.
17. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86-91.
18. Landry P, Danila I, Darioli R, Burnier M, Genton B. Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox. J Travel Med. 2006;13:8-14.
19. Brisson M, Brisson P. Compliance with antimalaria chemoprophylaxis in a combat zone. Am J Trop Med Hyg. 2012;86:587-90.
20. Annual Reports of the Anti Malaria Campaign, Sri Lanka. Colombo: Ministry of Health; 2008-2013.
21. WHO/Global Health Science Group. Eliminating Malaria. Case study-3. Progress towards elimination in Sri Lanka. 2012. http://www.who.int/malaria/publications/atoz/9789241504454/en/. Accessed 30 Dec 2016.
22. Smith DL, Cohen JM, Chiyaka C, Johnston G, Gething PW, Gosling R, et al. A sticky situation: the unexpected stability of malaria elimination. Philos Trans R Soc Lond B Biol Sci. 2013;368:1623.
23. Polio Global Eradication Initiative. 2106. http://polioeradication.org/polio-today/polio-now/this-week/. Accessed 30 Dec 2016.